AGOMELATINE IN CHILDREN AND ADOLESCENTS WITH MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER: 2-YEAR OPEN-LABEL EXTENSION STUDY

被引:0
|
作者
Falissard, B. [1 ]
Buitelaar, J. K. [2 ,3 ]
Fegert, J. M. [4 ]
Penelaud, P. F. [5 ]
Marx, U. [6 ]
Picarel-Blanchot, F. [7 ]
Arango, C. [8 ]
机构
[1] Sante Mentale & Sante Publ, Ctr Rech Epidemiol & Sante Populat, INSERM, U018, Paris, France
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands
[3] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands
[4] Univ Hosp Ulm, Dept Child & Adolescent Psychiat Psychotherapy, Ulm, Germany
[5] Inst Rech Int Servier, Ctr Therapeut Innovat, Suresnes, France
[6] Servier Forsch & Pharma, Munich, Germany
[7] Global Med & Patient Affairs GMPA, Internal Med & Neuropsychiat, Suresnes, France
[8] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, IiSGM,Sch Med, Madrid, Spain
来源
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [31] SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 144 - 144
  • [32] Effect of lurasidone on neurocognitive performance in children and adolescents with bipolar depression: interim analysis at week 52 of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 68 - 69
  • [33] Effect of lurasidone on cognition in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S79 - S79
  • [34] Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Otero, I. Hernandez
    Banaschewski, T.
    Johnson, M.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Yan, B.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S130 - S130
  • [35] Modafinil as augmentation of SSRI monotherapy in major depressive disorder: A 12-week, open-label extension study
    Thase, ME
    Fava, M
    DeBattista, C
    Fannelli, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S238 - S238
  • [36] An open-label, flexible-dose study of memantine in major depressive disorder
    Ferguson, James M.
    Shingleton, Richard N.
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) : 136 - 144
  • [37] Open-label tiagabine monotherapy for major depressive disorder with anxiety
    Carpenter, LL
    Schecter, JM
    Tyrka, AR
    Mello, AF
    Mello, MF
    Haggarty, R
    Price, LH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 66 - 71
  • [38] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [39] Effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 65 - 65
  • [40] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 133 - 133